-
Predictive value of q waves in inferior leads for the diagnosis of old inferior wall myocardial infarction
Zameer Abedin, Jennifer Dochee, David Gough, Moeen Abedin, Tariq Siddiqi, Debabrata Mukherjee, Zuber D Mulla, Zainul Abedin
Research Article: Clinical Investigation
-
Predictive value of q waves in inferior leads for the diagnosis of old inferior wall myocardial infarction
Zameer Abedin, Jennifer Dochee, David Gough, Moeen Abedin, Tariq Siddiqi, Debabrata Mukherjee, Zuber D Mulla, Zainul Abedin
Research Article: Clinical Investigation
-
Predictive value of q waves in inferior leads for the diagnosis of old inferior wall myocardial infarction
Zameer Abedin, Jennifer Dochee, David Gough, Moeen Abedin, Tariq Siddiqi, Debabrata Mukherjee, Zuber D Mulla, Zainul Abedin
Research Article: Clinical Investigation
-
Predictive value of q waves in inferior leads for the diagnosis of old inferior wall myocardial infarction
Zameer Abedin, Jennifer Dochee, David Gough, Moeen Abedin, Tariq Siddiqi, Debabrata Mukherjee, Zuber D Mulla, Zainul Abedin
Research Article: Clinical Investigation
-
Predictive value of q waves in inferior leads for the diagnosis of old inferior wall myocardial infarction
Zameer Abedin, Jennifer Dochee, David Gough, Moeen Abedin, Tariq Siddiqi, Debabrata Mukherjee, Zuber D Mulla, Zainul Abedin
Research Article: Clinical Investigation
-
Predictive value of q waves in inferior leads for the diagnosis of old inferior wall myocardial infarction
Zameer Abedin, Jennifer Dochee, David Gough, Moeen Abedin, Tariq Siddiqi, Debabrata Mukherjee, Zuber D Mulla, Zainul Abedin
Research Article: Clinical Investigation
-
Predictive value of q waves in inferior leads for the diagnosis of old inferior wall myocardial infarction
Zameer Abedin, Jennifer Dochee, David Gough, Moeen Abedin, Tariq Siddiqi, Debabrata Mukherjee, Zuber D Mulla, Zainul Abedin
Research Article: Clinical Investigation
-
Predictive value of q waves in inferior leads for the diagnosis of old inferior wall myocardial infarction
Zameer Abedin, Jennifer Dochee, David Gough, Moeen Abedin, Tariq Siddiqi, Debabrata Mukherjee, Zuber D Mulla, Zainul Abedin
Research Article: Clinical Investigation
-
Parathyroid hormone replacement in hypoparathyroidism
Sharon H Chou & Tamara Vokes
Clinical Trail Outcomes: Clinical Investigation
-
Parathyroid hormone replacement in hypoparathyroidism
Sharon H Chou & Tamara Vokes
Clinical Trail Outcomes: Clinical Investigation
-
Parathyroid hormone replacement in hypoparathyroidism
Sharon H Chou & Tamara Vokes
Clinical Trail Outcomes: Clinical Investigation
-
Parathyroid hormone replacement in hypoparathyroidism
Sharon H Chou & Tamara Vokes
Clinical Trail Outcomes: Clinical Investigation
-
Parathyroid hormone replacement in hypoparathyroidism
Sharon H Chou & Tamara Vokes
Clinical Trail Outcomes: Clinical Investigation
-
Parathyroid hormone replacement in hypoparathyroidism
Sharon H Chou & Tamara Vokes
Clinical Trail Outcomes: Clinical Investigation
-
Parathyroid hormone replacement in hypoparathyroidism
Sharon H Chou & Tamara Vokes
Clinical Trail Outcomes: Clinical Investigation
-
Parathyroid hormone replacement in hypoparathyroidism
Sharon H Chou & Tamara Vokes
Clinical Trail Outcomes: Clinical Investigation
-
Clinical progress for enterovirus 71 vaccines: what does the future hold?
Jing-Xin Li, Feng-Cai Zhu
Editorial: Clinical Investigation
-
Clinical progress for enterovirus 71 vaccines: what does the future hold?
Jing-Xin Li, Feng-Cai Zhu
Editorial: Clinical Investigation
-
Clinical progress for enterovirus 71 vaccines: what does the future hold?
Jing-Xin Li, Feng-Cai Zhu
Editorial: Clinical Investigation
-
Clinical progress for enterovirus 71 vaccines: what does the future hold?
Jing-Xin Li, Feng-Cai Zhu
Editorial: Clinical Investigation
-
Clinical progress for enterovirus 71 vaccines: what does the future hold?
Jing-Xin Li, Feng-Cai Zhu
Editorial: Clinical Investigation
-
Clinical progress for enterovirus 71 vaccines: what does the future hold?
Jing-Xin Li, Feng-Cai Zhu
Editorial: Clinical Investigation
-
Clinical progress for enterovirus 71 vaccines: what does the future hold?
Jing-Xin Li, Feng-Cai Zhu
Editorial: Clinical Investigation
-
Clinical progress for enterovirus 71 vaccines: what does the future hold?
Jing-Xin Li, Feng-Cai Zhu
Editorial: Clinical Investigation
-
The phosphatidyl-inositol 3-kinase/Akt/ mammalian target of rapamycin pathway as a therapeutic target in head and neck cancer
Saad A Khan & Julie E Bauman
Clinical Trail Outcomes: Clinical Investigation
-
The phosphatidyl-inositol 3-kinase/Akt/ mammalian target of rapamycin pathway as a therapeutic target in head and neck cancer
Saad A Khan & Julie E Bauman
Clinical Trail Outcomes: Clinical Investigation
-
The phosphatidyl-inositol 3-kinase/Akt/ mammalian target of rapamycin pathway as a therapeutic target in head and neck cancer
Saad A Khan & Julie E Bauman
Clinical Trail Outcomes: Clinical Investigation
-
The phosphatidyl-inositol 3-kinase/Akt/ mammalian target of rapamycin pathway as a therapeutic target in head and neck cancer
Saad A Khan & Julie E Bauman
Clinical Trail Outcomes: Clinical Investigation
-
The phosphatidyl-inositol 3-kinase/Akt/ mammalian target of rapamycin pathway as a therapeutic target in head and neck cancer
Saad A Khan & Julie E Bauman
Clinical Trail Outcomes: Clinical Investigation
-
The phosphatidyl-inositol 3-kinase/Akt/ mammalian target of rapamycin pathway as a therapeutic target in head and neck cancer
Saad A Khan & Julie E Bauman
Clinical Trail Outcomes: Clinical Investigation
-
The phosphatidyl-inositol 3-kinase/Akt/ mammalian target of rapamycin pathway as a therapeutic target in head and neck cancer
Saad A Khan & Julie E Bauman
Clinical Trail Outcomes: Clinical Investigation
-
The phosphatidyl-inositol 3-kinase/Akt/ mammalian target of rapamycin pathway as a therapeutic target in head and neck cancer
Saad A Khan & Julie E Bauman
Clinical Trail Outcomes: Clinical Investigation
-
The Medicines for Children Research Network: building on current success as we move forward
Sabah G Attar, Vanessa Poustie & Michael W Beresford
Research Update: Clinical Investigation
-
The Medicines for Children Research Network: building on current success as we move forward
Sabah G Attar, Vanessa Poustie & Michael W Beresford
Research Update: Clinical Investigation
-
The Medicines for Children Research Network: building on current success as we move forward
Sabah G Attar, Vanessa Poustie & Michael W Beresford
Research Update: Clinical Investigation
-
The Medicines for Children Research Network: building on current success as we move forward
Sabah G Attar, Vanessa Poustie & Michael W Beresford
Research Update: Clinical Investigation
-
The Medicines for Children Research Network: building on current success as we move forward
Sabah G Attar, Vanessa Poustie & Michael W Beresford
Research Update: Clinical Investigation
-
The Medicines for Children Research Network: building on current success as we move forward
Sabah G Attar, Vanessa Poustie & Michael W Beresford
Research Update: Clinical Investigation
-
The Medicines for Children Research Network: building on current success as we move forward
Sabah G Attar, Vanessa Poustie & Michael W Beresford
Research Update: Clinical Investigation
-
The Medicines for Children Research Network: building on current success as we move forward
Sabah G Attar, Vanessa Poustie & Michael W Beresford
Research Update: Clinical Investigation
-
Chloroquine enjoys a renaissance as an antineoplastic therapy
Virginia Espina, Lance A Liotta
Therapeutic Prospective: Clinical Investigation
-
Chloroquine enjoys a renaissance as an antineoplastic therapy
Virginia Espina, Lance A Liotta
Therapeutic Prospective: Clinical Investigation
-
Chloroquine enjoys a renaissance as an antineoplastic therapy
Virginia Espina, Lance A Liotta
Therapeutic Prospective: Clinical Investigation
-
Chloroquine enjoys a renaissance as an antineoplastic therapy
Virginia Espina, Lance A Liotta
Therapeutic Prospective: Clinical Investigation
-
Chloroquine enjoys a renaissance as an antineoplastic therapy
Virginia Espina, Lance A Liotta
Therapeutic Prospective: Clinical Investigation
-
Chloroquine enjoys a renaissance as an antineoplastic therapy
Virginia Espina, Lance A Liotta
Therapeutic Prospective: Clinical Investigation
-
Chloroquine enjoys a renaissance as an antineoplastic therapy
Virginia Espina, Lance A Liotta
Therapeutic Prospective: Clinical Investigation
-
Chloroquine enjoys a renaissance as an antineoplastic therapy
Virginia Espina, Lance A Liotta
Therapeutic Prospective: Clinical Investigation
-
Essential thrombocythemia: new advances in an old disease
Clodagh Keohane , Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Essential thrombocythemia: new advances in an old disease
Clodagh Keohane , Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Essential thrombocythemia: new advances in an old disease
Clodagh Keohane , Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Essential thrombocythemia: new advances in an old disease
Clodagh Keohane , Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Essential thrombocythemia: new advances in an old disease
Clodagh Keohane , Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Essential thrombocythemia: new advances in an old disease
Clodagh Keohane , Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Essential thrombocythemia: new advances in an old disease
Clodagh Keohane , Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Essential thrombocythemia: new advances in an old disease
Clodagh Keohane , Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
US FDA approves trastuzumab for the treatment of HER2-positive metastatic stomach cancer
News and Views: Clinical Investigation
-
US FDA approves trastuzumab for the treatment of HER2-positive metastatic stomach cancer
News and Views: Clinical Investigation
-
US FDA approves trastuzumab for the treatment of HER2-positive metastatic stomach cancer
News and Views: Clinical Investigation
-
US FDA approves trastuzumab for the treatment of HER2-positive metastatic stomach cancer
News and Views: Clinical Investigation
-
US FDA approves trastuzumab for the treatment of HER2-positive metastatic stomach cancer
News and Views: Clinical Investigation
-
US FDA approves trastuzumab for the treatment of HER2-positive metastatic stomach cancer
News and Views: Clinical Investigation
-
US FDA approves trastuzumab for the treatment of HER2-positive metastatic stomach cancer
News and Views: Clinical Investigation
-
US FDA approves trastuzumab for the treatment of HER2-positive metastatic stomach cancer
News and Views: Clinical Investigation
-
Research in acute decompensated heart failure: challenges and opportunities
Brian C Hiestand
Clinical Trail Outcomes: Clinical Investigation
-
Research in acute decompensated heart failure: challenges and opportunities
Brian C Hiestand
Clinical Trail Outcomes: Clinical Investigation
-
Research in acute decompensated heart failure: challenges and opportunities
Brian C Hiestand
Clinical Trail Outcomes: Clinical Investigation
-
Research in acute decompensated heart failure: challenges and opportunities
Brian C Hiestand
Clinical Trail Outcomes: Clinical Investigation
-
Research in acute decompensated heart failure: challenges and opportunities
Brian C Hiestand
Clinical Trail Outcomes: Clinical Investigation
-
Research in acute decompensated heart failure: challenges and opportunities
Brian C Hiestand
Clinical Trail Outcomes: Clinical Investigation
-
Research in acute decompensated heart failure: challenges and opportunities
Brian C Hiestand
Clinical Trail Outcomes: Clinical Investigation
-
Research in acute decompensated heart failure: challenges and opportunities
Brian C Hiestand
Clinical Trail Outcomes: Clinical Investigation
-
Combination therapy for renal cell carcinoma: review of the clinical evidence
David F McDermott, Keith T Flaherty
Review Article: Clinical Investigation
-
Combination therapy for renal cell carcinoma: review of the clinical evidence
David F McDermott, Keith T Flaherty
Review Article: Clinical Investigation
-
Combination therapy for renal cell carcinoma: review of the clinical evidence
David F McDermott, Keith T Flaherty
Review Article: Clinical Investigation
-
Combination therapy for renal cell carcinoma: review of the clinical evidence
David F McDermott, Keith T Flaherty
Review Article: Clinical Investigation
-
Combination therapy for renal cell carcinoma: review of the clinical evidence
David F McDermott, Keith T Flaherty
Review Article: Clinical Investigation
-
Combination therapy for renal cell carcinoma: review of the clinical evidence
David F McDermott, Keith T Flaherty
Review Article: Clinical Investigation
-
Combination therapy for renal cell carcinoma: review of the clinical evidence
David F McDermott, Keith T Flaherty
Review Article: Clinical Investigation
-
Combination therapy for renal cell carcinoma: review of the clinical evidence
David F McDermott, Keith T Flaherty
Review Article: Clinical Investigation